The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence
- PMID: 9469465
The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence
Abstract
The hepatitis B precore Ag (HBeAg) is a secreted nonparticulate version of the viral nucleocapsid hepatitis B core Ag (HBcAg), and its function is unknown. A proportion of HBeAg-specific Th cells evade deletion/anergy in HBeAg-transgenic (Tg) mice and mediate anti-HBe "autoantibody" (autoAb) production after in vivo activation with the appropriate Th cell peptide. This model system was used to determine how secretory HBeAg may effect deletion of Th cells in the periphery. For this purpose, HBeAg-Tg mice were bred with Fas and Fas ligand (FasL)-defective lpr/lpr and gld/gld mutant mice. Fas-FasL interactions mediate activation-induced apoptosis in the periphery. In HBeAg-Tg/+ mice, high-titrated anti-HBe autoAb was produced that was exclusively composed of the IgG1 isotype (i.e., Th2-like profile). In contrast, HBeAg-Tg/lpr and HBeAg-Tg/gld mice produced significantly less anti-HBe autoAb, and the IgG isotype patterns were broadened to include IgG2a, IgG2b and IgG3 as well as IgG1 (i.e., mixed Th1/Th2-like profile). These results suggest that HBeAg-specific Th1 cells are preferentially depleted by Fas-FasL-mediated interactions. The effect of circulating HBeAg on HBcAg-specific Th1 cells was also examined by transferring HBe/HBcAg-specific Th cells into dual HBeAg- and HBcAg-expressing Tg recipient mice. The presence of serum HBeAg ablated the expected Th1-mediated anti-HBc Ab response and shifted it toward a Th2 phenotype. These results suggest that in the context of a hepatitis B viral infection, circulating HBeAg has the potential to preferentially deplete inflammatory HBeAg- and HBcAg-specific Th1 cells that are necessary for viral clearance, thereby promoting hepatitis B virus persistence.
Similar articles
-
The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.J Virol. 1997 Mar;71(3):2192-201. doi: 10.1128/JVI.71.3.2192-2201.1997. J Virol. 1997. PMID: 9032353 Free PMC article.
-
Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice.J Immunol. 1994 Jan 15;152(2):455-66. J Immunol. 1994. PMID: 8283030
-
Comparative immunogenicity of hepatitis B virus core and E antigens.J Immunol. 1988 Nov 15;141(10):3617-24. J Immunol. 1988. PMID: 2460543
-
The immune response induced by hepatitis B virus principal antigens.Cell Mol Immunol. 2006 Apr;3(2):97-106. Cell Mol Immunol. 2006. PMID: 16696896 Review.
-
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.Hepatology. 2003 Nov;38(5):1075-86. doi: 10.1053/jhep.2003.50453. Hepatology. 2003. PMID: 14578844 Review.
Cited by
-
Hepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1).Virol J. 2013 Jul 12;10:232. doi: 10.1186/1743-422X-10-232. Virol J. 2013. PMID: 23849342 Free PMC article.
-
Mathematical models of e-antigen mediated immune tolerance and activation following prenatal HBV infection.PLoS One. 2012;7(7):e39591. doi: 10.1371/journal.pone.0039591. Epub 2012 Jul 2. PLoS One. 2012. PMID: 22768303 Free PMC article.
-
Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load.World J Gastroenterol. 2009 Jul 21;15(27):3382-93. doi: 10.3748/wjg.15.3382. World J Gastroenterol. 2009. PMID: 19610139 Free PMC article.
-
Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action.Sci Rep. 2017 May 11;7(1):1729. doi: 10.1038/s41598-017-01773-6. Sci Rep. 2017. PMID: 28496097 Free PMC article.
-
Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.Antimicrob Agents Chemother. 2008 Jan;52(1):312-20. doi: 10.1128/AAC.00467-07. Epub 2007 Nov 5. Antimicrob Agents Chemother. 2008. PMID: 17984230 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous